Form 4: Intuitive Surgical SVP Mark Brosius Reports Stock Transactions

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, reports transactions involving common stock and Restricted Stock Units (RSUs).

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical, filed a Form 4 detailing several transactions.
• On February 27, 2025, 4,385 shares of common stock were acquired due to the certification of performance goals under performance stock units (PSUs).
• On February 28, 2025, 877 shares were acquired through the exercise of Restricted Stock Units (RSUs).
• Also on February 28, 2025, 435 shares were disposed of to cover tax withholding requirements related to the RSU vesting at a price of $563.77.
• An additional 2,175 shares were disposed of on February 28, 2025, to cover taxes applicable to a settlement of PSUs at a price of $563.77.
• On March 3, 2025, 492 shares were sold at a price of $573.78, pursuant to a pre-arranged trading plan under SEC Rule 10b5-1.
• Following these transactions, Brosius directly owns 4,056 shares of Intuitive Surgical common stock and 877 Restricted Stock Units.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions appear to be routine and related to stock-based compensation and tax obligations. There is no indication of unusual or concerning activity.

Positives

• The acquisition of shares through PSU certification and RSU vesting indicates that performance goals were met and that the executive is incentivized to increase shareholder value.

Negatives

• The disposal of shares to cover tax obligations reduces the executive's direct holdings in the company.

Risks

• Executive stock sales, even for tax purposes, can sometimes be perceived negatively by the market.

Future Outlook

The executive's future transactions may be influenced by the vesting schedule of RSUs and the terms of the 10b5-1 trading plan.

Industry Context

Insider transactions are closely monitored in the medical device industry to gauge executive sentiment and potential future performance of the company.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice in financial analysis, with firms like Verition and InsiderScore tracking Form 4 filings to assess market sentiment.
• Companies like Stryker (SYK) and Medtronic (MDT) also see regular Form 4 filings from their executives, reflecting the common use of stock-based compensation in the industry.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small volume of shares involved.

Key Dates